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Dear Editor, E xperimental science depends on models, especially basic biological research, where animal models can lead us to the comprehension of several phenomena that otherwise would be hardly accessible in humans. By definition, a model is a simplification of a system which is assumed similar to the one being represented. However, every model has limitations due to the difficulty of including all aspects of the reality that is intended to be reproduced.
Animal models on low carbohydrate high fat (LCHF) diets are a good example of these limitations. Although different kinds of LCHF has been associated with good results in human clinical trials (1,2), especially in insulin resistance subjects (3,4), animal models not always reproduce the same beneficial effects, as we could see in Lamont and cols. (5), who recently publish in Nutrition & Diabetes, which induced fat mass gain and glucose intolerance in pre-diabetic New Zealand Obese (NZO) mice through their submission to LCHF diet.
The effects of LCHF diet in murine models are inconsistent and dependent on several variables, from the animal model used up to changes in experimental diets. For example: Diet induced obesity has already been reversed with a ketogenic LCHF diet in mice (6), while LCHF induced weight gain in Lamont and cols. (5) or has not affected weight of ob/ob mice, although prevented the progression of hepatic steatosis (7). Still, others describe hepatic steatosis in mice after administration of the same diet (8) . In addition, the deficiency of choline (a B-complex vitamin) in the commercial LCHF diet used has been pointed as a cause of hepatic mitochondrial dysfunction and fat accumulation found in these LCHF feed mice, instead the macronutrient proportion (9) .
As far as we could see, Lamont and cols. (5) used an own LCFH diet, and were careful about micronutrients contain (including choline). On the other hand, sucrose content (10%) was one among other differences used in diets (as Bio-Serv F3666 diet which is carbohydrate/sucrose free) and was likely added to improve palatability and acceptance of the diet. We don't know how and how much this detail may have impacted on the effects of LCHF diet in NZO mice, especially considering their hyperphagic behavior, probably due to leptin resistance and hyperinsulinemia during early age (10) .
Likewise, it seems that these endocrine features of NZO (Leptin resistance and hyperinsulinemia) are inevitable, different of human obesity and type II diabetes, or others animal models, where a decrease of both hormones and increased satiety are induce by LCHF diet and may be an important part beneficial effects found (11, 12) .
In short, considering the limitations present in different experimental models and the beneficial results reported by clinical trials (1-4), in our opinion LCHF diets are still an accessible and encouraged option of non-pharmacological intervention for hu- 
